8°c Overcast
5°c Variable cloudiness
The Canadian Press - ONLINE EDITION
GlaxoSmithKline Q4 and full-year profits rise as restructuring pays off
The GlaxoSmithKline offices in London, Wednesday, April 28, 2010. THE CANADIAN PRESS/AP, Kirsty Wigglesworth
LONDON - Restructuring and reduced overheads helped GlaxoSmithKline PLC return to profit in the fourth quarter, with the UK drug maker adding that the U.K. drug maker was optimistic about new product development this year.
For the three months ending Dec. 31, GSK on Tuesday reported a worse-than-expected net profit of 1.25 billion pounds (US$1.98 billion) compared with a loss of 633 million pounds a year earlier.
Revenue also fell short of analyst forecasts, down 3 per cent at 6.98 billion pounds.
For the full year, net profit more than trebled, from 1.63 billion pounds in 2010 to 5.26 billion pounds last year. Revenue was down 3.5 per cent to 27.4 billion pounds.
Sales and administration costs were slashed by a third to 8.8 billion pounds. Restructuring costs of 150 million pounds were roughly half the previous year's figures.
The company said it planned to extend its share repurchase program by 1 billion pounds to 2 billion pounds, after spending 2.2 billion pounds on buybacks last year.
GSK shares were down 1.8 per cent at 1,394 pence following the report's release.
Keith Bowman, analyst at Hargreaves Lansdown Stockbrokers, said the fourth-quarter results were at the lower end of expectations.
"Pricing pressure has been seen across a number of the group's markets, while the company's R&D efforts are yet to yield what the group itself sees as an acceptable return," Bowman said.
Chief Executive Andrew Witty said 2011 sales were up 4 per cent excluding the exceptional bulge in vaccine sales a year earlier. He was optimistic about the development of new products this year.
"I am pleased to confirm that of the 15 late-stage drugs and vaccines we highlighted last year, we have received some or all of the data on nine of them," Witty said.
"Most importantly, one has already filed and we have three more ready to file. In addition, our quadrivalent flu vaccine, which was not included in the 15, has progressed very quickly and will also file very shortly."
More Business
- Back to Top
- Return to Business
Poll
Proudly brought to you by:
Most Popular Business
- Forest fire forces closure of gold mine in Timmins area
- Jets boost TSN Radio, CJOB takes hit
- RIM stock falls as BlackBerry maker's global sales head quits
- Proud to be a tortoise: Great-West takes it slow and steady
- City seen as ideal rail hub for Canada, Mexico trade
- Astral sale OK'd, CEO pay nixed
- 50 highest-paid CEOs in AP survey
- Touch of Paris in crepe eatery on Esplanade
- Compensation due in shaky Facebook IPO, source says
- Canadian dollar moves lower for eighth session, commodity prices advance
- Manitoba gets first female land surveyor
- Big week for Facebook's Zuckerberg: From IPO opening bells to wedding bells
- Tempers flare on CP picket line on McPhillips Street
- Committee pitches 9-6 Sunday shopping
- Investment fraudster gets 10 years
- Forest fire forces closure of gold mine in Timmins area
- Canadian Pacific workers give 72 hour strike notice as negotiations continue
- Jets boost TSN Radio, CJOB takes hit
- New crepe eatery to be unveiled for Esplanade
- Manitoba Movers
- Boston Pizza franchise mushrooming locally
- Hecla resort finally gets offer
- Manitoba gets first female land surveyor
- Major CWB layoffs underway
- Big week for Facebook's Zuckerberg: From IPO opening bells to wedding bells
- WestJet eyes new routes, seat plans
- No such thing as a bad job, Flaherty tells picky unemployed workers
- Canadian credit card system of fees 'perverse,' raises prices: Competition Bureau
- What happens if Greece leaves the euro zone?
- Ford's outbursts tarnishing Toronto's image, experts warn in wake of latest feud
- Shoppers Drug Mart signs agreement to buy pharmacies from Paragon
- CRTC awards licence for new Calgary FM radio station, The PEAK
- Catalyst Paper says it did not get enough approval for restructuring plan
- Royal Caribbean sending 2 cruise liners to China, says they will be Asia's largest
- Proud to be a tortoise: Great-West takes it slow and steady
- Rush of ageism to beat new law
- Cost of federal payouts hits $2B
- New EI rules take aim at frequent users, force workers to accept lower pay
- Dorel foresees juvenile sales growth opportunities from Target arrival in Canada
- Jet engine maker Pratt & Whitney cuts 300 US jobs, citing business conditions
- Shoppers Drug Mart signs agreement to buy pharmacies from Paragon
- Avoid merger mess Include HR professionals in preparing for change
- Manitoba gets first female land surveyor
- Catalyst Paper says it did not get enough approval for restructuring plan
- Women honoured at awards dinner
- Long haul 'family' Every employee is a spoke in the wheel at Bison Transport
- Snowbirds, Americans living in Canada read on...
- Walmart Canada to slash prices further to take on discount competition
- Manitoba Movers
- Toronto investment company buys three blocks for $100M
- Loss is New Flyer's gain
- Empty inside
- Major CWB layoffs underway
- Shoppers Drug Mart signs agreement to buy pharmacies from Paragon
- Snowbirds, Americans living in Canada read on...
- James E. Marker, inventor of Cheezies, dies in Belleville, Ont., at age 90
- Pershing Square gaining ground in Canadian Pacific proxy battle, poll suggests
- Hecla resort finally gets offer
- Avoid merger mess Include HR professionals in preparing for change
- Manitoba gets first female land surveyor
Ads by Google
You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.
The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010; View the changes. New to commenting? Check out our Frequently Asked Questions.